Capstone Financial Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $992K | Sell |
8,244
-619
| -7% | -$71.5K | 0.05% | 63 |
|
|
2025
Q4 | $933K | Sell |
8,863
-150
| -2% | -$14.1K | 0.05% | 66 |
|
|
2025
Q3 | $756K | Sell |
9,013
-16
| -0.2% | -$1.32K | 0.04% | 78 |
|
|
2025
Q2 | $715K | Sell |
9,029
-381
| -4% | -$30.3K | 0.04% | 80 |
|
|
2025
Q1 | $845K | Sell |
9,410
-658
| -7% | -$61.4K | 0.05% | 65 |
|
|
2024
Q4 | $1M | Buy |
10,068
+23
| +0.2% | +$2.37K | 0.06% | 64 |
|
|
2024
Q3 | $1.14M | Sell |
10,045
-97
| -1% | -$11.5K | 0.07% | 56 |
|
|
2024
Q2 | $1.26M | Buy |
10,142
+203
| +2% | +$26.1K | 0.08% | 48 |
|
|
2024
Q1 | $1.31M | Buy |
9,939
+663
| +7% | +$81.7K | 0.09% | 48 |
|
|
2023
Q4 | $1.01M | Buy |
9,276
+656
| +8% | +$68.1K | 0.07% | 53 |
|
|
2023
Q3 | $887K | Buy |
8,620
+3
| +0% | +$323 | 0.07% | 54 |
|
|
2023
Q2 | $994K | Buy |
8,617
+448
| +5% | +$50.9K | 0.07% | 53 |
|
|
2023
Q1 | $869K | Buy |
8,169
+2
| +0% | +$216 | 0.07% | 54 |
|
|
2022
Q4 | $906K | Sell |
8,167
-444
| -5% | -$45.4K | 0.08% | 49 |
|
|
2022
Q3 | $742K | Buy |
8,611
+207
| +2% | +$18.5K | 0.07% | 54 |
|
|
2022
Q2 | $766K | Buy |
8,404
+7
| +0.1% | +$621 | 0.07% | 59 |
|
|
2022
Q1 | $689K | Buy |
8,397
+212
| +3% | +$16.7K | 0.05% | 61 |
|
|
2021
Q4 | $627K | Buy |
8,185
+4
| +0% | +$319 | 0.05% | 67 |
|
|
2021
Q3 | $614K | Buy |
8,181
+510
| +7% | +$38.8K | 0.05% | 59 |
|
|
2021
Q2 | $597K | Buy |
7,671
+3,492
| +84% | +$260K | 0.05% | 60 |
|
|
2021
Q1 | $307K | Hold |
4,179
| – | – | 0.03% | 84 |
|
|
2020
Q4 | $326K | Buy |
4,179
+600
| +17% | +$45.9K | 0.03% | 75 |
|
|
2020
Q3 | $283K | Hold |
3,579
| – | – | 0.03% | 78 |
|
|
2020
Q2 | $264K | Hold |
3,579
| – | – | 0.03% | 76 |
|
|
2020
Q1 | $263K | Sell |
3,579
-1,637
| -31% | -$129K | 0.03% | 62 |
|
|
2019
Q4 | $453K | Buy |
5,216
+136
| +3% | +$11.2K | 0.06% | 46 |
|
|
2019
Q3 | $408K | Buy |
5,080
+1,711
| +51% | +$137K | 0.06% | 47 |
|
|
2019
Q2 | $270K | Hold |
3,369
| – | – | 0.04% | 70 |
|
|
2019
Q1 | $267K | Buy |
3,369
+326
| +11% | +$24.4K | 0.05% | 67 |
|
|
2018
Q4 | $222K | Hold |
3,043
| – | – | 0.04% | 72 |
|
|
2018
Q3 | $206K | Buy |
+3,043
| New | +$194K | 0.05% | 75 |
|
|
2016
Q1 | – | Sell |
-4,664
| Closed | -$235K | – | 73 |
|
|
2015
Q4 | $235K | Sell |
4,664
-314
| -6% | -$15.8K | 0.08% | 55 |
|
|
2015
Q3 | $235K | Sell |
4,978
-90
| -2% | -$4.78K | 0.1% | 52 |
|
|
2015
Q2 | $275K | Sell |
5,068
-2,107
| -29% | -$118K | 0.11% | 61 |
|
|
2015
Q1 | $394K | Buy |
7,175
+1,884
| +36% | +$107K | 0.15% | 47 |
|
|
2014
Q4 | $287K | Sell |
5,291
-161
| -3% | -$8.97K | 0.09% | 56 |
|
|
2014
Q3 | $308K | Buy |
+5,452
| New | +$306K | 0.19% | 40 |
|
Other funds holding MRK
VCM
VPM
Capstone Financial Advisors's MRK Position: Q1 2026 in Review
Capstone Financial Advisors reduced its Merck (MRK) stake by 7% in Q1 2026, selling an estimated $71.5K and leaving 8,244 shares worth $992K. The position accounts for 0.05% of the portfolio, ranked #63.
Capstone Financial Advisors first reported a position in MRK in Q3 2014 and has held it in 37 quarters since. The position peaked at $1.31M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Capstone Financial Advisors held 8,244 shares of Merck worth $992K as of Q1 2026.
- Capstone Financial Advisors sold 619 Merck shares in Q1 2026, an estimated $71.5K.
- Merck made up 0.05% of Capstone Financial Advisors's portfolio in Q1 2026, its #63 holding.
- Capstone Financial Advisors first reported a position in Merck in Q3 2014 and has held it in 37 quarters since.
- Capstone Financial Advisors's Merck position peaked at $1.31M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Capstone Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.